Breast Cancer

ASCO 2026 highlighted advances in pancreatic, breast, sarcoma, lung and prostate cancers that may reshape treatment.

A breast cancer survivor shares the discovery of a new kidney mass and details how she will be a smarter, more assertive patient if it is cancer.

Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic triple-negative breast cancer.

I thought I understood breast cancer, until a routine conversation at the pharmacy changed everything.

ASCO 2026: Telephone-based weight loss significantly improves physical function and mental health in patients with breast cancer patients who are overweight or obese.

Giredestrant plus Afinitor improved disease control after later treatment and delayed chemotherapy in ER-positive, HER2-negative breast cancer.

Giredestrant plus Afinitor may help patients with metastatic breast cancer delay chemotherapy and stay on effective treatment longer.

OPTIMA trial data at ASCO 2026 shows a 50-gene test helps patients with high-risk breast cancer avoid unnecessary and toxic chemotherapy treatments.

Discover five breakthrough breast cancer studies disrupting oncology as global research teams unveil practice-changing data at ASCO 2026 in Chicago.

An inspiring BRCA2 survivor shares her mastectomy journey, launching the Dear Body Project to help women find healing, self-love and community.

Discover how mastectomy-induced sensation loss impacts body image and intimacy, and learn how breast cancer survivors can advocate for their recovery.

A BRCA2-positive previvor shares her 20-year journey, offering empowering advice and community support for those navigating genetic mutation news.

A retired teacher’s plans for "Act II" are derailed by a breast cancer diagnosis, bringing an onslaught of appointments and a double mastectomy.

CURE editor-in-chief Dr. Joshua Sabari explores how ctDNA liquid biopsies could transform breast cancer care while balancing costs and patient anxiety.

FDA approved Datroway for unresectable or metastatic triple-negative breast cancer not eligible for PD-1 or PD-L1 therapy with PFS, OS and response rates vs chemotherapy.

Study finds breast cancer patients with vitamin D deficiency are three times more likely to report moderate pain and receive more opioids after surgery

Breast cancer survivor Erica Deligne advocates for body autonomy and challenges the medical industry’s default toward breast reconstruction.

Oncology nurse Tammy Zinn, an Extraordinary Healer finalist, expanded support through wish-granting programs, counseling and survivorship care for patients with cancer.

Dr. Erica Mayer of Dana-Farber highlights new data on chemotherapy-free HER2+ treatment, ctDNA monitoring and oral SERDs at ESMO Breast 2026.

The FDA approved Enhertu for presurgical HER2+ breast cancer treatment. Dr. Shanu Modi discusses the "win-win" for patient efficacy and safety.

A survivor shares why advocating for a mammogram past age 75 led to a crucial second diagnosis and why family history means staying vigilant for life.

New research suggests biologic aging and neighborhood-related stress may affect how aerobic exercise influences cognition after breast cancer treatment.

A moving journey through breast cancer, discovering that vulnerability is courage and a diagnosis doesn't have to define your spirit or faith.

The FDA approved Enhertu for certain patients with HER2-positive early-stage breast cancer before and after surgery based on DESTINY trial data.

My experience with cancer has affected the way I think about the health of my pets. Whereas the old me was more fatalistic, the survivor in me would go an extra mile to save a beloved creature.